Max Robotics — Global Service Robot Directory + US Certification

About

IRCCS Ospedale San Raffaele stands at the forefront of clinical robotics research, seamlessly bridging cutting-edge surgical innovation with advanced neurorehabilitation science. Based in Milan, Italy, this prestigious institute has established itself as one of Europe's premier centers for robot-assisted medicine, with deep expertise spanning urological surgery, neurological rehabilitation, and minimally invasive procedures. In the surgical arena, San Raffaele's urology division has generated landmark contributions to robot-assisted radical prostatectomy, partial nephrectomy, and radical cystectomy. Their research on learning curves for robotic prostatectomy and their leadership in the ROSULA Collaborative Group for managing complex T2 renal tumors have shaped international clinical standards. Notably, their work contributed to defining the European Association of Urology Robotics (ERUS) curriculum for robot-assisted partial nephrectomy, directly influencing how surgeons across the continent are trained and certified. Their early adoption of the Hugo robotic system further signals a commitment to pioneering next-generation platforms. Equally impressive is San Raffaele's neurorehabilitation program, which has produced rigorous randomized controlled trials demonstrating the efficacy of robot-assisted therapy for stroke recovery and Parkinson's disease rehabilitation. From upper limb exoskeletons to gait-training systems, their clinical evidence has helped legitimize robotic rehabilitation as a standard-of-care intervention worldwide. With dozens of highly cited publications, multicenter collaborations across Europe, and prospective trial data informing global guidelines, IRCCS Ospedale San Raffaele represents an exceptional environment for researchers and clinicians seeking to advance the intersection of robotics and medicine. Prospective collaborators and students will find here a culture of rigorous evidence generation, translational ambition, and genuine clinical impact.